HUT70766A - Pharmaceutical compositions containing immune stimulants for preventing bacterial infections - Google Patents
Pharmaceutical compositions containing immune stimulants for preventing bacterial infectionsInfo
- Publication number
- HUT70766A HUT70766A HU9401775A HU9401775A HUT70766A HU T70766 A HUT70766 A HU T70766A HU 9401775 A HU9401775 A HU 9401775A HU 9401775 A HU9401775 A HU 9401775A HU T70766 A HUT70766 A HU T70766A
- Authority
- HU
- Hungary
- Prior art keywords
- pharmaceutical compositions
- compositions containing
- bacterial infections
- preventing bacterial
- containing immune
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/415—1,2-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US7784693A | 1993-06-15 | 1993-06-15 | |
US12210893A | 1993-09-16 | 1993-09-16 |
Publications (2)
Publication Number | Publication Date |
---|---|
HU9401775D0 HU9401775D0 (en) | 1994-09-28 |
HUT70766A true HUT70766A (en) | 1995-10-30 |
Family
ID=26759749
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9401775A HUT70766A (en) | 1993-06-15 | 1994-06-14 | Pharmaceutical compositions containing immune stimulants for preventing bacterial infections |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP0703782A1 (xx) |
JP (1) | JPH08506353A (xx) |
AU (1) | AU6436394A (xx) |
CA (1) | CA2165344A1 (xx) |
HU (1) | HUT70766A (xx) |
IL (1) | IL109953A0 (xx) |
WO (1) | WO1994028898A1 (xx) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2513064B1 (en) | 2009-12-17 | 2018-07-04 | Katholieke Universiteit Leuven, K.U. Leuven R&D | Compounds, compositions and methods for controlling biofilms |
US9133123B2 (en) | 2010-04-23 | 2015-09-15 | Cytokinetics, Inc. | Certain amino-pyridines and amino-triazines, compositions thereof, and methods for their use |
AR081626A1 (es) | 2010-04-23 | 2012-10-10 | Cytokinetics Inc | Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos |
AR081331A1 (es) | 2010-04-23 | 2012-08-08 | Cytokinetics Inc | Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos |
US8759380B2 (en) | 2011-04-22 | 2014-06-24 | Cytokinetics, Inc. | Certain heterocycles, compositions thereof, and methods for their use |
CN110237075A (zh) * | 2019-06-25 | 2019-09-17 | 华中农业大学 | 一种达氟沙星在治疗副猪嗜血杆菌药物中的用途 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4435396A (en) * | 1982-05-10 | 1984-03-06 | Pfizer Inc. | Antiulcer 2-guanidino-4-(2-substituted-amino-4-imidazolyl)thiazoles and process therefor |
US4560690A (en) * | 1984-04-30 | 1985-12-24 | Pfizer Inc. | 2-(N-substituted guanidino)-4-hetero-arylthiazole antiulcer agents |
US4636498A (en) * | 1984-10-11 | 1987-01-13 | Pfizer Inc. | Formulation of antiinflammatory drugs |
US4591595A (en) * | 1984-10-11 | 1986-05-27 | Pfizer Inc. | 2-guanidino-4-(2-methyl-4-imidazolyl)thiazoles in the treatment of rheumatoid arthritis |
IL85472A (en) * | 1987-03-09 | 1991-06-30 | Procter & Gamble | Pharmaceutical compositions for treating gastrointestinal disorders |
GB9120131D0 (en) * | 1991-09-20 | 1991-11-06 | Glaxo Group Ltd | Medicaments |
US5294433A (en) * | 1992-04-15 | 1994-03-15 | The Procter & Gamble Company | Use of H-2 antagonists for treatment of gingivitis |
-
1994
- 1994-04-26 JP JP7501532A patent/JPH08506353A/ja active Pending
- 1994-04-26 EP EP94912051A patent/EP0703782A1/en not_active Withdrawn
- 1994-04-26 WO PCT/IB1994/000082 patent/WO1994028898A1/en not_active Application Discontinuation
- 1994-04-26 CA CA002165344A patent/CA2165344A1/en not_active Abandoned
- 1994-04-26 AU AU64363/94A patent/AU6436394A/en not_active Abandoned
- 1994-06-09 IL IL10995394A patent/IL109953A0/xx unknown
- 1994-06-14 HU HU9401775A patent/HUT70766A/hu unknown
Also Published As
Publication number | Publication date |
---|---|
JPH08506353A (ja) | 1996-07-09 |
HU9401775D0 (en) | 1994-09-28 |
EP0703782A1 (en) | 1996-04-03 |
IL109953A0 (en) | 1994-10-07 |
CA2165344A1 (en) | 1994-12-22 |
AU6436394A (en) | 1995-01-03 |
WO1994028898A1 (en) | 1994-12-22 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
GB2251791B (en) | Pharmaceutical compositions containing benzenesulphonamides | |
HU9303143D0 (en) | Pharmaceutical compositions | |
ZA922834B (en) | Pharmaceutical compositions | |
IL110201A0 (en) | Novel pharmaceutical compositions | |
GB9200253D0 (en) | Pharmaceutical compositions | |
GB9115893D0 (en) | Pharmaceutical compositions | |
HUT70766A (en) | Pharmaceutical compositions containing immune stimulants for preventing bacterial infections | |
GB9111314D0 (en) | Pharmaceutical compositions | |
GB9023023D0 (en) | Pharmaceutical compositions | |
ZA925171B (en) | Pharmaceutical compositions | |
AU2537992A (en) | Pharmaceutical compositions | |
GB9026080D0 (en) | Pharmaceutical compositions | |
GB9003185D0 (en) | Pharmaceutical compositions | |
GB9121631D0 (en) | Pharmaceutical compositions | |
GB9015435D0 (en) | Pharmaceutical compositions | |
GB9200414D0 (en) | Pharmaceutical compositions | |
AU9016891A (en) | Pharmaceutical compositions | |
GB9113621D0 (en) | Pharmaceutical compositions | |
GB9113805D0 (en) | Pharmaceutical compositions | |
GB9121989D0 (en) | Pharmaceutical compositions | |
GB9121291D0 (en) | Pharmaceutical compositions | |
GB9107278D0 (en) | Pharmaceutical compositions | |
GB9119048D0 (en) | Pharmaceutical compositions | |
GB9123423D0 (en) | Pharmaceutical compositions | |
GB9118481D0 (en) | Pharmaceutical compositions |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
DFD9 | Temporary protection cancelled due to non-payment of fee |